Zdrowie i gospodarka · 17/01/2025
FDA Announces Draft Guidance for Industry on Chemotherapy-Induced Peripheral Neuropathy
The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for chemotherapy-induced peripheral neuropathy, a painful condition that can affect cancer patients' survival.